LivingGLP1
Study S003392

Visualizing Beta Cells After Intrahepatic Islet of Langerhans Transplantation

Registration

Registration
NCT03785236
Acronym
GLP1-transpl
Study type
OBSERVATIONAL
Status
TERMINATED
Enrollment
13
Start
2016-06-06
Primary completion
2021-05-27
Lead sponsor
Radboud University Medical Center
Conditions
Type 1 Diabetes Mellitus
Interventions
RADIATION:68Ga-NODAGA-exendin PET/CT
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Hepatic uptake of 68Ga-NODAGA-exendin-4 [1 year]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0016888Monitoring β-Cell Survival After Intrahepatic Islet Transplantation Using Dynamic Exendin PET Imaging: A Proof-of-Concept Study in Individuals With Type 1 Diabetes.
Jansen TJP, Diabetes
2023OtherPMID 37068261DOIcites ClinicalTrials.gov:NCT03785236